Healthcare provider profile · identity verified

Rick A Erdman, MD

Internal Medicine · TOMAH, WI · NPI 1952306011

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	780	184
Metoprolol Succinate	Metoprolol Succinate	478	119
Lisinopril	Lisinopril	423	98
Metformin Hcl Er	Metformin Hcl	347	92
Levothyroxine Sodium	Levothyroxine Sodium	340	63
Omeprazole	Omeprazole	324	84
Amlodipine Besylate	Amlodipine Besylate	283	83
Eliquis	Apixaban	216	43
Rosuvastatin Calcium	Rosuvastatin Calcium	199	62
Simvastatin	Simvastatin	195	46
Tamsulosin Hcl	Tamsulosin Hcl	192	53
Furosemide	Furosemide	164	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	153	37
Chlorthalidone	Chlorthalidone	132	33
Losartan Potassium	Losartan Potassium	120	36
Allopurinol	Allopurinol	113	29
Gabapentin	Gabapentin	106	33
Duloxetine Hcl	Duloxetine Hcl	101	26
Sertraline Hcl	Sertraline Hcl	96	18
Metoprolol Tartrate	Metoprolol Tartrate	94	27
Pantoprazole Sodium	Pantoprazole Sodium	93	20
Hydrochlorothiazide	Hydrochlorothiazide	90	26
Metformin Hcl	Metformin Hcl	87	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	83	20
Trulicity	Dulaglutide	83	19
Escitalopram Oxalate	Escitalopram Oxalate	76	15
Jardiance	Empagliflozin	75	18
Glimepiride	Glimepiride	72	16
Clopidogrel	Clopidogrel Bisulfate	70	13
Xarelto	Rivaroxaban	70	15
Memantine Hcl	Memantine Hcl	67	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	67	17
Warfarin Sodium	Warfarin Sodium	65	13
Lamotrigine	Lamotrigine	63	suppressed
Nitroglycerin	Nitroglycerin	63	41
Shingrix	Varicella-Zoster Ge/As01b/Pf	63	46
Trazodone Hcl	Trazodone Hcl	63	16
Albuterol Sulfate Hfa	Albuterol Sulfate	62	25
Finasteride	Finasteride	61	17
Fluoxetine Hcl	Fluoxetine Hcl	60	12
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Potassium Chloride	Potassium Chloride	55	13
Carvedilol	Carvedilol	54	13
Doxazosin Mesylate	Doxazosin Mesylate	52	13
Fluticasone Propionate	Fluticasone Propionate	50	27
Mirtazapine	Mirtazapine	47	13
Lorazepam	Lorazepam	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	15
Atenolol	Atenolol	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Famotidine	Famotidine	40	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	15
Olanzapine	Olanzapine	38	suppressed
Atropine Sulfate	Atropine Sulfate	37	suppressed
Lovastatin	Lovastatin	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	21
Aripiprazole	Aripiprazole	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	26	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Prednisone	Prednisone	25	19
Insulin Aspart Flexpen	Insulin Aspart	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Ramipril	Ramipril	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	21	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Mesalamine	Mesalamine	20	suppressed
Ozempic	Semaglutide	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Clozapine	Clozapine	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Baclofen	Baclofen	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Digoxin	Digoxin	15	suppressed
Nystatin	Nystatin	15	suppressed
Nystop	Nystatin	15	suppressed
Torsemide	Torsemide	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Loxapine	Loxapine Succinate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Valsartan	Valsartan	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Tetracycline Hcl	Tetracycline Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error